Results 11 to 20 of about 28,167 (192)
Antiphospholipid Syndrome [PDF]
Translational Research, 2008 Antiphospholipid syndrome is one of the more common acquired causes of hypercoagulability. Its major presentations are thrombotic (arterial, venous, or microvascular) and pregnancy morbidity (miscarriages, late intrauterine fetal demise, and severe pre-eclampsia).
Cervera, Ricard, Espinosa, Gerard
openaire +6 more sources
Antiphospholipid Syndrome [PDF]
Best Practice & Research Clinical Rheumatology, 2016 Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy morbidity. Thrombosis is one of the major disease mechanisms, mainly caused by activating endothelial cells, monocytes, and platelets.
Khamashta, M. +3 more
openaire +5 more sources
International Archives of Allergy and Immunology, 2000 Antiphospholipid syndrome (APS) is a disease characterized by venous and arterial thromboses or spontaneous abortions and the repeated detection of antiphospholipid antibodies (aPL). APS may be associated with another autoimmune disease (secondary APS), particularly systemic lupus erythematosus (SLE), or unrelated to an underlying disease (primary APS).
E, Gromnica-Ihle, W, Schössler
+7 more sources
Journal of Investigative Dermatology, 1993 The antiphospholipid antibodies (aPL), namely, the lupus anticoagulant and the anticardiolipin antibodies, are a family of autoantibodies directed predominantly against negatively charged phospholipids. Many studies have confirmed that patients with these antibodies are prone to repeated episodes of thrombosis, fetal losses, and thrombocytopenia.
Asherson, Ronald A., Cervera, Ricard
openaire +2 more sources
RETROSPECTIVE ANALYSIS OF MEDICAL CHARTS OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
Медична наука України, 2023 Background. Antiphospholipid attracts the attention of clinicians in various fields of medicine. This pathology is characterized by a triad of clinical and laboratory signs: recurrent venous or arterial thrombosis with localization in any part of the ...
V. I. Savytskyi
doaj +1 more source
Catastrophic antiphospholipid syndrome presenting as fever of unknown origin
Saudi Journal of Kidney Diseases and Transplantation, 2012 Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies with characteristic clinical manifestation, which include venous, arterial thrombosis, thrombotic microangiopathy, and recurrent fetal loss.
Fatma I Al-Beladi
doaj +1 more source
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
Journal of Investigative Medicine High Impact Case Reports, 2023 COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome.
Lauren Bitterman MD +5 more
doaj +1 more source
Renal Involvement in Antiphospholipid Syndrome
Frontiers in Immunology, 2018 Antiphospholipid syndrome is a complex autoimmune disease, characterized by the presence of vascular thrombosis, obstetric, hematologic, cutaneous, and cardiac manifestations. Renal disease in patients with antiphospholipid syndrome was not recognized in
Alonso Turrent-Carriles +2 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 Antiphospholipid syndrome is an autoimmune disorder characterized by arterial and venous thrombosis and recurrent spontaneous abortions due to the persistent presence of antiphospholipid antibodies.
Seyed M Nahidi +6 more
doaj +1 more source
Rheumatology, 2018 Antiphospholipid syndrome is a cause of arterial and venous thrombosis especially in the young adult population. Although dural sinus thrombosis is a relatively rare complication of antiphospholipid syndrome, it may be a cause of morbidity and mortality.
Ufuk İlgen, Sezin Turan, Hakan Emmungil
doaj +1 more source